Skip to content
Bone Wizardry
Hereditary polyposis syndromes: gene, polyp, phenotype

GI

Hereditary polyposis syndromes: gene, polyp, phenotype

The inheritance pattern narrows the gene; the polyp histology narrows the syndrome; the extracolonic findings close the loop.

Primary diagnostic image
Diffuse adenoma burden should trigger hereditary-syndrome reasoning rather than management as an isolated polyp.Netha Hussain / Wikimedia Commons (CC BY-SA 3.0). Source CC BY-SA 3.0
  • Match FAP, attenuated FAP, Gardner and Turcot phenotypes, Peutz-Jeghers syndrome, juvenile polyposis, and MUTYH polyposis to genes, inheritance, and polyp type.
  • Recognize extracolonic findings that identify a hereditary polyposis syndrome and expand cancer surveillance.
  • Choose syndrome-specific endoscopic surveillance and recognize when prophylactic or burden-driven surgery is indicated.

Progression ladder

Follow progression from driver to treatment

The figure separates tumor initiation, progression, staging, and treatment decisions.

Quick check

A 16-year-old has hundreds of colorectal adenomas, congenital hypertrophy of the retinal pigment epithelium, mandibular osteomas, and epidermoid cysts. His father had colectomy at age 24.

Which molecular diagnosis best explains the phenotype?

Recall gene and inheritance without mixing the syndromes

The family tree can distinguish APC from MUTYH before sequencing returns.

APC, STK11, SMAD4, and BMPR1A syndromes are usually visible in successive generations because they are autosomal dominant. Biallelic MUTYH disease can cluster among siblings while parents are unaffected carriers.

Turcot syndrome is a historical phenotype pairing colorectal polyposis or Lynch-spectrum disease with a primary brain tumor: APC is classically associated with medulloblastoma, while mismatch-repair disease is associated with glioma.

Select the accurate gene-inheritance pairing.

Unaffected parents do not exclude hereditary polyposis; they are exactly what an autosomal recessive MUTYH pedigree may show.

Move from phenotype to lifetime prevention

Testing is useful only when it changes surveillance for the patient and relatives.

Document cumulative polyp number, histology, age, family history, and extracolonic findings before selecting germline testing. Multigene panels are appropriate when phenotypes overlap.

A pathogenic result establishes inheritance, triggers cascade testing, and selects colorectal and extracolonic surveillance. Surgery is based on cancer, symptoms, dysplasia, burden, and ability to clear the colon endoscopically.

Order the hereditary polyposis workup and prevention pathway.

Choose the first step.

Compare syndromes on four axes

Gene, inheritance, polyp histology, and extracolonic phenotype should agree.

APC-associated polyposis and the STK11, SMAD4, and BMPR1A hamartomatous syndromes are autosomal dominant. MUTYH-associated polyposis requires biallelic pathogenic variants and is autosomal recessive.

FAP and MUTYH polyposis are predominantly adenomatous. Peutz-Jeghers and juvenile polyposis are hamartomatous but still carry substantial gastrointestinal and extraintestinal cancer risk.

Match each syndrome to its defining pattern.

A hamartomatous polyp syndrome is not benign; histology describes architecture, not lifetime cancer risk.

Map the extracolonic organs that expose the syndrome

The colon may be the loudest organ, but it is not the only organ at risk.

APC-associated disease extends to duodenal and ampullary adenomas, desmoid tumors, thyroid cancer, osteomas, dental anomalies, epidermoid cysts, retinal findings, and selected CNS tumors.

Peutz-Jeghers requires small-bowel and multisystem cancer surveillance. Juvenile polyposis may involve stomach and colon, and SMAD4 disease can add epistaxis, telangiectasias, and arteriovenous malformations.

Map each organ clue to its strongest syndrome signal.

1Jaw, skin, retina, and desmoid tissue

Osteomas, epidermoid cysts, congenital retinal pigment changes, and desmoids support an APC Gardner phenotype.

2Brain

Medulloblastoma with APC polyposis or glioma with mismatch-repair disease fits the historical Turcot phenotype.

3Lips, buccal mucosa, and small bowel

Mucocutaneous melanin and small-bowel hamartomatous polyps point to Peutz-Jeghers syndrome.

4Stomach, nose, skin, and pulmonary vessels

Gastric juvenile polyps plus telangiectasias, epistaxis, or AVMs suggest SMAD4-associated juvenile polyposis with HHT.

5Duodenum and thyroid

Upper-GI adenomas and thyroid cancer surveillance remain important after APC-related colorectal surgery.

Anchor surveillance to the age when risk becomes actionable

The numbers differ because classic APC disease declares itself earlier than the attenuated and hamartomatous syndromes.

Classic FAP screening generally begins at age 10 to 15 years. Attenuated FAP begins in late adolescence, and biallelic MUTYH colonoscopy begins around age 25 to 30 years.

Peutz-Jeghers gastrointestinal assessment begins in childhood because intussusception can precede cancer; juvenile polyposis endoscopy starts by about age 15 years or earlier with symptoms.

Place typical starting ages on the surveillance axis.

Peutz-Jeghers baseline GI evaluation
Classic FAP lower-GI surveillance
Juvenile polyposis endoscopy
Attenuated FAP lower-GI surveillance
Biallelic MUTYH colonoscopy
Score: 0 / 0

Open the surveillance and surgery rules by syndrome

Endoscopy delays cancer only while the polyp burden remains safely controllable.

Classic FAP lower-GI surveillance begins around age 10 to 15 years and continues every 1 to 2 years; colectomy is required for cancer or major symptoms and is strongly considered for unmanageable burden, high-grade dysplasia, large adenomas, or rapid progression.

Peutz-Jeghers, juvenile polyposis, and biallelic MUTYH each require syndrome-specific endoscopy. Surgery is not automatic for every hamartomatous polyp or attenuated adenoma burden, but obstruction, bleeding, cancer, dysplasia, or failure of endoscopic control changes the balance.

Reveal the management trigger behind each syndrome.

Prophylactic colorectal surgery prevents one major cancer pathway but does not end upper-GI or extracolonic surveillance.

Stage 1 of 3: Overview

Overview

Hereditary polyposis syndromes: gene, polyp, phenotype

Testing is useful only when it changes surveillance for the patient and relatives.

Work through the oncology pathway

Five pedigrees combine polyp histology with a clue outside the colon. The pattern chooses testing, surveillance, and sometimes surgery.

Cross out stage mismatches and highlight the treatment-changing clue. Each case separates biology, stage, and intent.

A 17-year-old with more than 500 colorectal adenomas has a mandibular osteoma, impacted supernumerary teeth, and an abdominal desmoid tumor. His mother had the same findings.

Which syndrome description is most precise?

Tumor-board pivot

Choose the finding that changes the pathway

Choose the feature that changes diagnosis, stage, or treatment intent.

Which molecular diagnosis best explains the phenotype?

Rapid review

Three questions to check

Which molecular diagnosis best explains the phenotype?

A heterozygous pathogenic APC variant causing classic FAP with Gardner features. Autosomal dominant APC polyposis causes hundreds of adenomas; osteomas, epidermoid cysts, dental findings, and desmoids define the Gardner phenotypic cluster.

Is the inheritance dominant or recessive?

The affected parent and child support autosomal dominant inheritance.

Is the adenoma burden attenuated?

No. More than 500 adolescent adenomas is classic FAP.

Related GI topics

GIColon polyps: histology, pathway, and surveillanceA polyp name matters only after size, number, histology, location, and completeness of removal are integrated.GIColorectal Cancer: Find It, Stage It, Treat ItLaterality changes the first clue, but tissue diagnosis and anatomic stage determine the next move.GILynch syndrome: from tumor mismatch repair to preventionThe tumor raises the flag; germline testing establishes the inherited diagnosis.

Medically reviewed

Fatima Ali, DO

Fatima Ali, DO

PGY-1 Resident Physician in Psychiatry

University Hospitals, Columbia

DO from Kansas City University

Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.

Languages: English, Urdu

Primary reviewerFull physician profile

Medically reviewed

Sources

  1. APC-Associated Polyposis Conditions2022
  2. Peutz-Jeghers Syndrome2021
  3. Juvenile Polyposis Syndrome2022
  4. MUTYH Polyposis2021

Bone Wizardry is a study resource for medical students. It is not medical advice.